{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:52:45Z","timestamp":1780725165263,"version":"3.54.1"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["2682"],"award-info":[{"award-number":["2682"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"Canadian Consortium on Neurodegeneration in Aging","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]},{"name":"Canadian Institute of Health Research","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"Canadian Institute of Health Research","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"Canadian Institute of Health Research","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"Canadian Institute of Health Research","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"Canadian Institute of Health Research","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"Canadian Institute of Health Research","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]},{"name":"Compute Canada Resources for Research Groups","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"Compute Canada Resources for Research Groups","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"Compute Canada Resources for Research Groups","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"Compute Canada Resources for Research Groups","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"Compute Canada Resources for Research Groups","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"Compute Canada Resources for Research Groups","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]},{"name":"CIHR Foundation","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"CIHR Foundation","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"CIHR Foundation","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"CIHR Foundation","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"CIHR Foundation","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"CIHR Foundation","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]},{"name":"CIHR Project","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"CIHR Project","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"CIHR Project","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"CIHR Project","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"CIHR Project","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"CIHR Project","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]},{"name":"ProMIS Neurosciences","award":["TR201519"],"award-info":[{"award-number":["TR201519"]}]},{"name":"ProMIS Neurosciences","award":["20R04367"],"award-info":[{"award-number":["20R04367"]}]},{"name":"ProMIS Neurosciences","award":["2682"],"award-info":[{"award-number":["2682"]}]},{"name":"ProMIS Neurosciences","award":["RRG 3071"],"award-info":[{"award-number":["RRG 3071"]}]},{"name":"ProMIS Neurosciences","award":["FDN-143228"],"award-info":[{"award-number":["FDN-143228"]}]},{"name":"ProMIS Neurosciences","award":["PJT-168907"],"award-info":[{"award-number":["PJT-168907"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Misfolded toxic forms of alpha-synuclein (\u03b1-Syn) have been implicated in the pathogenesis of synucleinopathies, including Parkinson\u2019s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The \u03b1-Syn oligomers and soluble fibrils have been shown to mediate neurotoxicity and cell-to-cell propagation of pathology. To generate antibodies capable of selectively targeting pathogenic forms of \u03b1-Syn, computational modeling was used to predict conformational epitopes likely to become exposed on oligomers and small soluble fibrils, but not on monomers or fully formed insoluble fibrils. Cyclic peptide scaffolds reproducing these conformational epitopes exhibited neurotoxicity and seeding activity, indicating their biological relevance. Immunization with the conformational epitopes gave rise to monoclonal antibodies (mAbs) with the desired binding profile showing selectivity for toxic \u03b1-Syn oligomers and soluble fibrils, with little or no reactivity with monomers, physiologic tetramers, or Lewy bodies. Recognition of naturally occurring soluble \u03b1-Syn aggregates in brain extracts from DLB and MSA patients was confirmed by surface plasmon resonance (SPR). In addition, the mAbs inhibited the seeding activity of sonicated pre-formed fibrils (PFFs) in a thioflavin-T fluorescence-based aggregation assay. In neuronal cultures, the mAbs protected primary rat neurons from toxic \u03b1-Syn oligomers, reduced the uptake of PFFs, and inhibited the induction of pathogenic phosphorylated aggregates of endogenous \u03b1-Syn. Protective antibodies selective for pathogenic species of \u03b1-Syn, as opposed to pan \u03b1-Syn reactivity, are expected to provide enhanced safety and therapeutic potency by preserving normal \u03b1-Syn function and minimizing the diversion of active antibody from the target by the more abundant non-toxic forms of \u03b1-Syn in the circulation and central nervous system.<\/jats:p>","DOI":"10.3390\/biomedicines10092168","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:48:25Z","timestamp":1662410905000},"page":"2168","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein"],"prefix":"10.3390","volume":"10","author":[{"given":"Ebrima","family":"Gibbs","sequence":"first","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Roman","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Plotkin","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubiao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5348-7877","authenticated-orcid":false,"given":"Shawn C. C.","family":"Hsueh","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-7452","authenticated-orcid":false,"given":"Adekunle","family":"Aina","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay","family":"Shyu","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-9501","authenticated-orcid":false,"given":"Calvin K.","family":"Yip","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Eun","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne M.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"ProMIS Neurosciences, Cambridge, MA 02142, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Cashman","sequence":"additional","affiliation":[{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T 1Z1, Canada"},{"name":"ProMIS Neurosciences, Cambridge, MA 02142, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target alpha-synuclein pathology","volume":"298","author":"Brundin","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: A new hope","volume":"134","author":"Roberts","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105010","DOI":"10.1016\/j.nbd.2020.105010","article-title":"Passive immunotherapies targeting Abeta and tau in Alzheimer\u2019s disease","volume":"144","author":"Plotkin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnmol.2019.00262","article-title":"Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis","volume":"12","author":"McAlary","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.celrep.2017.12.009","article-title":"Prion-like Propagation of alpha-Synuclein Is Regulated by the FcgammaRIIB-SHP-1\/2 Signaling Pathway in Neurons","volume":"22","author":"Choi","year":"2018","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fnins.2019.00552","article-title":"Prion-Like Mechanisms in Parkinson\u2019s Disease","volume":"13","author":"Ma","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-017-0445-5","article-title":"Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology","volume":"5","author":"Ngolab","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological alpha-synuclein in brain","volume":"136","author":"Nonaka","year":"2013","journal-title":"Brain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104582","DOI":"10.1016\/j.nbd.2019.104582","article-title":"Preclinical development of a high affinity alpha-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular alpha-synuclein and attenuate alpha-synuclein spreading in vivo","volume":"132","author":"Schofield","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nasstrom, T., Goncalves, S., Sahlin, C., Nordstrom, E., Screpanti Sundquist, V., Lannfelt, L., Bergstrom, J., Outeiro, T.F., and Ingelsson, M. (2011). Antibodies against alpha-synuclein reduce oligomerization in living cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027230"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Masliah, E., Rockenstein, E., Mante, M., Crews, L., Spencer, B., Adame, A., Patrick, C., Trejo, M., Ubhi, K., and Rohn, T.T. (2011). Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019338"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The Synaptic Function of alpha-Synuclein","volume":"5","author":"Burre","year":"2015","journal-title":"J. Parkinsons. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","article-title":"Abrogating Native alpha-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson\u2019s Disease","volume":"100","author":"Nuber","year":"2018","journal-title":"Neuron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.1505953112","article-title":"KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity","volume":"112","author":"Dettmer","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acschemneuro.1c00567","article-title":"Optimizing Epitope Conformational Ensembles Using alpha-Synuclein Cyclic Peptide \"Glycindel\" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson\u2019s Disease","volume":"13","author":"Hsueh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11662","DOI":"10.1021\/acs.jpcb.8b07680","article-title":"Prediction of Misfolding-Specific Epitopes in SOD1 Using Collective Coordinates","volume":"122","author":"Peng","year":"2018","journal-title":"J. Phys. Chem. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/09622802211002861","article-title":"A method for systematically ranking therapeutic drug candidates using multiple uncertain screening criteria","volume":"30","author":"Peng","year":"2021","journal-title":"Stat. Methods Med. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","article-title":"Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson\u2019s Disease in Rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1039\/C8CC04054K","article-title":"Re-designing the alpha-synuclein tetramer","volume":"54","author":"Xu","year":"2018","journal-title":"Chem. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1073\/pnas.1014335108","article-title":"Structural plasticity within highly specific neuronal populations identifies a unique parcellation of motor learning in the adult brain","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1021\/acschemneuro.7b00446","article-title":"From a Highly Disordered to a Metastable State: Uncovering Insights of alpha-Synuclein","volume":"9","author":"Cote","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nbd.2018.10.016","article-title":"Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson\u2019s disease models","volume":"124","author":"Weihofen","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: Tools and therapies","volume":"150","author":"Vaikath","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2014.05.009","article-title":"Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice","volume":"69","author":"Lindstrom","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fnins.2018.00452","article-title":"Region-Specific Effects of Immunotherapy With Antibodies Targeting alpha-synuclein in a Transgenic Model of Synucleinopathy","volume":"12","author":"Kallab","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"705407","DOI":"10.3389\/fneur.2021.705407","article-title":"A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson\u2019s Disease (PASADENA): Rationale, Design, and Baseline Data","volume":"12","author":"Pagano","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Strohaker","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of alpha-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","article-title":"Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies","volume":"109","author":"Peng","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1038\/s41598-019-46306-5","article-title":"A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer\u2019s Disease","volume":"9","author":"Gibbs","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2168\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:22:22Z","timestamp":1760142142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["biomedicines10092168"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10092168","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}